XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Common stock
Preferred stock
Nonvested restricted stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings
Total
Beginning balance, value at Dec. 31, 2021 $ 79 $ (1,435) $ 114,226 $ (740) $ 165,771 $ 277,901
Beginning balance shares outstanding at Dec. 31, 2021 7,925,819          
Net income 15,210 15,210
Proceeds from exercise of stock options $ 1 706 707
Proceeds from exercise of stock options (in Shares) 21,750            
Issuance of restricted stock (2,305) 2,305
Issuance of restricted stock (in Shares) 38,075          
Compensation expense related to restricted stock, net of tax 510 510
Compensation expense related to stock options, net of tax 477 477
Other comprehensive income (loss) (9,403) (9,403)
Adoption of ASU 2016-13 (2,765) (2,765)
Ending balance, value at Jun. 30, 2022 $ 80 (3,230) 117,714 (10,143) 178,216 282,637
Ending balance shares outstanding at Jun. 30, 2022 7,985,644          
Beginning balance, value at Mar. 31, 2022 $ 80 (3,425) 117,286 (6,393) 170,976 278,524
Beginning balance shares outstanding at Mar. 31, 2022 7,980,519          
Net income 7,240 7,240
Proceeds from exercise of stock options 128 128
Proceeds from exercise of stock options (in Shares) 3,625          
Issuance of restricted stock (71) 71
Issuance of restricted stock (in Shares) 1,500          
Compensation expense related to restricted stock, net of tax 266 266
Compensation expense related to stock options, net of tax 229 229
Other comprehensive income (loss) (3,750) (3,750)
Ending balance, value at Jun. 30, 2022 $ 80 (3,230) 117,714 (10,143) 178,216 282,637
Ending balance shares outstanding at Jun. 30, 2022 7,985,644          
Beginning balance, value at Dec. 31, 2022 $ 80 (3,306) 119,027 (13,410) 192,121 294,512
Beginning balance shares outstanding at Dec. 31, 2022 8,011,045          
Net income 5,161 5,161
Proceeds from exercise of stock options $ 1 184 185
Proceeds from exercise of stock options (in Shares) 11,000            
Issuance of restricted stock (1,436) 1,436
Issuance of restricted stock (in Shares) 36,393          
Compensation expense related to restricted stock, net of tax 691 691
Compensation expense related to stock options, net of tax 265 265
Other comprehensive income (loss) 700 700
Ending balance, value at Jun. 30, 2023 $ 81 (4,051) 120,912 (12,710) 197,282 301,514
Ending balance shares outstanding at Jun. 30, 2023 8,058,438          
Beginning balance, value at Mar. 31, 2023 $ 80 (4,462) 120,683 (11,775) 194,824 299,350
Beginning balance shares outstanding at Mar. 31, 2023 8,047,975          
Net income 2,458 2,458
Proceeds from exercise of stock options $ 1 168 169
Proceeds from exercise of stock options (in Shares) 10,000            
Issuance of restricted stock 85 (85)
Issuance of restricted stock (in Shares) 463          
Compensation expense related to restricted stock, net of tax 326 326
Compensation expense related to stock options, net of tax 146 146
Other comprehensive income (loss) (935) (935)
Ending balance, value at Jun. 30, 2023 $ 81 $ (4,051) $ 120,912 $ (12,710) $ 197,282 $ 301,514
Ending balance shares outstanding at Jun. 30, 2023 8,058,438